Naringenin has been reported to improve learning and memory in Aβ or streptozotocin-injected AD models (Yang et al., 2014; Ghofrani et al., 2015), which might relate to the mitigation of lipid peroxidation and apoptosis or the increased insulin and insulin receptor expression in the rat brain. The gene discussed is INSR; the disease is Alzheimer disease.